Your session is about to expire
← Back to Search
High-intensity interval training (HIIT)-4 for Type 2 Diabetes
N/A
Recruiting
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, in fasted state
Awards & highlights
Study Summary
This trial will test if HIIT can help type 2 diabetics by reducing cardiovascular risks.
Eligible Conditions
- Type 2 Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, in fasted state
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, in fasted state
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in ambulatory systolic and diastolic blood pressure
Secondary outcome measures
Change in 24h glycemia
Change in arterial stiffness
Change in monocyte-derived macrophages polarization
+16 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Rest, HIIT-4, HIIT-10Experimental Treatment3 Interventions
Both arms start with the rest condition and the order of the two other conditions (HIIT-4 and HIIT-10) is determined at random.
This arm's sequence of intervention is : 1-Rest; 2- HIIT-4 and 3- HIIT-10.
Group II: Rest, HIIT-10, HIIT-4Experimental Treatment3 Interventions
Both arms start with the rest condition and the order of the two other conditions (HIIT-4 and HIIT-10) is determined at random.
This arm's sequence of intervention is : 1- Rest; 2- HIIT-10 and 3- HIIT-4.
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
298 Previous Clinical Trials
69,926 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger